70M gallons of cleaner aviation fuel to cut 600,000 MT CO2
Calumet (NASDAQ: CLMT) subsidiary Montana Renewables and World Energy have partnered to deliver over 70 million gallons of Sustainable Aviation Fuel (SAF) across three years, aiming to reduce CO2 emissions by up to 600,000 metric tons. This collaboration supports U.S. agriculture and energy independence, with Montana Renewables' MaxSAF™ 150 expansion progressing to meet demand. The long-term contract with World Energy validates MRL's capital investments and accelerates the supply of SAF.
Calumet stock (CLMT) slips in premarket after Friday surge, with Feb 27 earnings next
Calumet (CLMT) stock saw a 2.1% premarket dip after a 10.1% surge on February 13th, ahead of its Q4 and full-year 2025 earnings report on February 27th. Investors are keen on updates regarding cash generation, the balance between specialty products and renewables, and any changes in the company's financial outlook, especially after recent debt refinancings. The upcoming earnings call will be crucial for guidance, margin discussions, and renewable energy plans.
UBS Upgrades Calumet Inc(CLMT.US) to Hold Rating, Raises Target Price to $26
UBS analyst Manav Gupta has upgraded Calumet Inc (CLMT.US) to a hold rating from a previous rating, and significantly increased its target price from $15 to $26. Gupta has a strong track record, with a 68.3% success rate and an average return of 13.6% over the last year, according to TipRanks data. This information is provided for educational purposes and should not be considered investment advice.
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Rating of "Hold" from Analysts
Calumet, Inc. (NASDAQ:CLMT) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $22.83. Institutional investors hold approximately 34.41% of the stock, with significant recent buys, and shares opened at $28.61, near a 1-year high. The company, an independent provider of high-value petroleum and renewable feedstock solutions, has a market capitalization of $2.48 billion.
Calumet (NASDAQ:CLMT) Shares Up 11.2% - Here's What Happened
Calumet (NASDAQ:CLMT) shares surged 11.2% during mid-day trading on Friday, reaching $28.8850 on 50% lower than average volume. Despite the jump, analysts maintain a consensus "Hold" rating with an average price target of $22.83, and institutional investors collectively own about 34.41% of the company. Several firms modestly increased their positions in Q4, while some analysts recently downgraded or reiterated ratings.
Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2025 Earnings on February 27, 2026
Calumet, Inc. (NASDAQ: CLMT) announced it will release its Fourth Quarter and Fiscal Year 2025 financial results on February 27, 2026. A conference call for investors, analysts, and media is scheduled for the same day at 9:00 AM ET, featuring a live webcast and accompanying presentation slides. A replay of the call will be available on the company's investor relations website.
Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2025 Earnings on February 27, 2026
Calumet, Inc. (NASDAQ: CLMT) announced it will release its Fourth Quarter and Fiscal Year 2025 earnings on February 27, 2026. A conference call and webcast to discuss these results are scheduled for the same day at 9:00 AM ET. Investors and media can access the webcast or pre-register for the dial-in call.
Calumet stock hits 52-week high at 26.18 USD
Calumet Inc.'s stock reached a new 52-week high of $26.23, reflecting significant investor confidence, despite an InvestingPro analysis suggesting it's overvalued. The company recently completed a $405 million senior notes offering and extended its senior secured revolving credit facility, leading to a positive outlook revision from S&P Global Ratings. These financial maneuvers aim to improve its debt profile and liquidity, pushing its nearest material debt maturity to July 2028.
Calumet stock hits 52-week high at 26.18 USD By Investing.com
Calumet Inc.'s stock reached a new 52-week high of $26.23, reflecting a 47.56% return over the past year and an 81.68% surge in six months, despite an InvestingPro analysis indicating the stock is overvalued due to a substantial debt burden and negative EPS. The company recently completed a $405 million senior notes offering to redeem older debt and extended its revolving credit facility, leading to a positive outlook revision from S&P Global Ratings. These financial maneuvers aim to improve the company's debt profile and liquidity, pushing its nearest material debt maturity to July 2028.
Avoiding Lag: Real-Time Signals in (CLMT) Movement
This article analyzes Calumet Specialty Products Partners L.p. (CLMT) using AI models, identifying strong sentiment across all time horizons which supports an overweight bias. It presents three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop loss parameters. The analysis also highlights elevated downside risk due to the absence of additional long-term support signals.
Insiders At Calumet Sold US$4.7m In Stock, Alluding To Potential Weakness
Over the past year, insiders at Calumet, Inc. (NASDAQ:CLMT) sold a substantial US$4.7 million worth of stock, primarily through a large sale by an independent director at a price below the current market value. While insider selling can have various motivations, a high volume of sales might prompt shareholders to investigate further. Despite these sales, insiders still own 4.1% of Calumet shares, valued at around US$91 million, which is considered a reasonable degree of alignment with company interests.
BofA Securities Maintains Calumet Inc(CLMT.US) With Buy Rating, Announces Target Price $28
BofA Securities analyst Conor Fitzpatrick has maintained a Buy rating on Calumet Inc (CLMT.US) and set a target price of $28. Fitzpatrick has a strong track record, with a 100% success rate and a 27.9% average return over the past year, according to TipRanks data. This information is provided for educational purposes and is not an investment recommendation.
Calumet outlook revised to positive at S&P on debt refinancing and improved metrics
S&P Global Ratings has revised its outlook on Calumet Inc. to positive from stable, affirming its 'CCC+' rating, due to the company's successful debt refinancing. Calumet refinanced its 2026 and 2027 unsecured notes and extended its ABL maturity to July 2028, leading S&P to anticipate improved credit metrics and EBITDA margins over the coming 12-24 months, supported by favorable market conditions and increased sustainable aviation fuel production. An upgrade to 'B-' is possible if financial performance continues to strengthen, meeting specific debt to EBITDA and interest coverage targets.
July 17th Options Now Available For Calumet (CLMT)
New options contracts for Calumet Inc (CLMT) with a July 17th expiration date are now available, offering potential opportunities for option sellers due to 162 days until expiration. Specifically, a $19.00 strike put contract could yield an 8.30% annualized return if it expires worthless, and a $31.00 strike call contract, if sold as part of a covered call, could provide a 30.61% total return if the stock is called away. These options present strategies for investors interested in buying or holding CLMT shares, leveraging premium collection against potential stock price movements.
Calumet, Inc. (NASDAQ:CLMT) Stock Rockets 26% But Many Are Still Ignoring The Company
Calumet, Inc. (NASDAQ:CLMT) has seen its stock price jump 26% in the last month and 47% over the last year. Despite this growth, its price-to-sales (P/S) ratio of 0.5x is significantly lower than the industry average, suggesting investors may be overlooking its potential. While the company's revenue has declined in recent years, analysts forecast a 7.1% annual growth over the next three years, outpacing the industry's projected 5.1% growth, which makes its low P/S ratio peculiar.
Calumet, Inc. (NASDAQ:CLMT) Stock Rockets 26% But Many Are Still Ignoring The Company
Calumet, Inc. (NASDAQ:CLMT) has seen its stock jump 26% in the last month and 47% over the last year, yet its price-to-sales (P/S) ratio of 0.5x is considerably lower than the Oil and Gas industry average of 1.6x. Despite a recent decline in revenue, analysts forecast a 7.1% annual revenue growth for Calumet over the next three years, outpacing the industry's projected 5.1%. The article suggests that investor skepticism about the company's ability to meet these growth expectations may be contributing to its low P/S ratio.
Calumet outlook revised to positive at S&P on debt refinancing and improved metrics
S&P Global Ratings has revised its outlook on Calumet Inc. to positive from stable, while affirming its 'CCC+' rating after successful debt refinancing. The company issued new unsecured notes to refinance existing debt and extended its ABL maturity, pushing debt maturity to July 2028. S&P expects Calumet's credit metrics to improve over the next year due to favorable market fundamentals, better product mix, and cost optimization, with EBITDA margins projected to reach 8% in 2025 and 10% in 2026/2027.
Calumet stock hits 52-week high at 23.44 USD
Calumet Specialty Products Partners (NASDAQ:CLMT) stock reached a 52-week high of $23.44, tripling from its 52-week low, and has seen significant rises over the past year and six months. Despite being flagged as overvalued and operating with a significant debt burden by InvestingPro, investor confidence is strong due to strategic initiatives and favorable market conditions. The company recently reported better-than-expected Q3 2025 earnings and completed a private placement of senior notes to refinance existing debt, further highlighting its robust financial maneuvers.
Discipline and Rules-Based Execution in CLMT Response
The article concerns Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), highlighted by strong sentiment across all horizons supporting an overweight bias. It presents three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, alongside a multi-timeframe signal analysis. The report also notes an exceptional 38.3:1 risk-reward short setup, targeting 11.6% downside versus 0.3% risk.
Great Lakes Advisors LLC Purchases Shares of 169,195 Calumet, Inc. $CLMT
Great Lakes Advisors LLC has purchased a new position of 169,195 shares in Calumet, Inc. (NASDAQ:CLMT) for approximately $3.088 million during the third quarter. This acquisition gives Great Lakes Advisors LLC about 0.20% of Calumet. Other institutional investors have also adjusted their holdings in the oil and gas company, which currently has a "Hold" consensus rating and a target price of $20.71 from analysts.
Calumet Signs Credit Agreement Amendment With Bank of America
Calumet (CLMT) has signed the Ninth Amendment to its Third Amended and Restated Credit Agreement with Bank of America, extending its asset-based revolving credit facility. The amendment extends the maturity to January 23, 2031, sets commitments at $500 million (subject to borrowing base), and updates covenants to allow for potential new inventory financing transactions, which would reduce total commitments to $425 million. Calumet anticipates these changes will improve its liquidity and financial flexibility.
Calumet extends senior secured revolving credit facility to 2031 By Investing.com
Calumet, Inc. (NASDAQ:CLMT) has extended its asset-based loan facility to January 2031 and increased total commitments to $500 million. This strategic move aims to improve the company's debt maturity profile and follows its recent successful private placement of $405 million in 9.75% Senior Notes due 2031, which will be used to redeem earlier senior notes. The stock has seen a significant price increase of 31.65% over the past six months, nearing its 52-week high.
Calumet pushes $500M credit line deadline back to 2031 with lenders
Calumet (NASDAQ: CLMT) has extended its a $500 million senior secured asset-based revolving credit facility from January 2027 to January 2031, led by Bank of America. This move expands their banking partners and optimizes borrowing capacity following the sale of the industrial Royal Purple business. The extension aims to lengthen the company's overall debt maturity profile and enhance financial flexibility.
Calumet stock hits 52-week high at 22.11 USD
Calumet Inc. stock reached a new 52-week high of $22.11 USD, reflecting a 32.29% total return over the past year and a 27.27% surge in the last six months to a market capitalization of $1.91 billion. Despite financial challenges like a $2.3 billion debt and negative EPS, the company recently reported strong Q3 2025 earnings and successfully completed a private placement of $405 million in Senior Notes to manage existing debt. Analyst targets for the stock range from $13.25 to $33, indicating mixed opinions on its future.
Should Calumet’s $405 Million High-Coupon Refi Shift Reshape the CLMT Debt Story?
Calumet recently completed an upsized private placement of $405 million in 9.75% Senior Notes due 2031, with net proceeds of about $393 million. This refinancing aims to redeem higher-coupon 2026 and 2027 senior notes, potentially lowering interest costs and adjusting the company's debt profile. While this move helps clean up the balance sheet, the company's ability to achieve consistent profitability, especially through its Montana Renewables project, and manage its significant debt load remain key concerns for investors.
Should Calumet’s $405 Million High-Coupon Refi Shift Reshape the CLMT Debt Story?
Calumet recently completed a $405 million private placement of 9.75% Senior Notes due 2031 to refinance higher-coupon 2026 and 2027 senior notes. This move aims to clean up the balance sheet rather than change the immediate catalyst for the company, which remains execution at Montana Renewables. The refinancing highlights Calumet's ongoing challenge of managing its significant debt load and the need for successful project execution to achieve consistent profitability.
Calumet, Inc. (NASDAQ:CLMT) Receives Average Recommendation of "Hold" from Analysts
Calumet, Inc. (NASDAQ:CLMT) has received an average "Hold" recommendation from eight analysts, with a consensus 12-month price target of $20.04. The company recently reported Q3 EPS of -$0.21, beating estimates, and revenue of $1.08 billion, also surpassing expectations. Shares are currently trading around $20.33, with a market capitalization of $1.76 billion.
Calumet completes $405 million senior notes offering at 9.75%
Calumet, Inc. (NASDAQ:CLMT) has successfully closed a private placement of $405 million in 9.75% Senior Notes due 2031, upsized from an initial $350 million. The company, which specializes in branded products and renewable fuels, plans to use the net proceeds, along with cash and revolving credit, to redeem its outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027, thereby optimizing its debt structure and eliminating near-term senior note maturities. This financial move follows a strong third quarter in 2025 where Calumet reported earnings per share of $3.61, significantly exceeding projections.
Calumet Target of Unusually Large Options Trading (NASDAQ:CLMT)
Calumet (NASDAQ:CLMT) experienced unusually high options trading, with investors purchasing 3,039 call options, a 22% increase over the typical daily volume. Despite mixed analyst opinions, the stock currently holds a "Hold" consensus rating with an average price target of $20.04. The company recently beat EPS estimates and reported $1.08 billion in revenue, while institutional investors have also adjusted their positions in the stock.
What Calumet (CLMT)'s Upsized 2031 Bond Refi Means For Shareholders
Calumet's subsidiaries completed an upsized private placement of US$405 million in 9.75% Senior Unsecured Notes due 2031 to refinance existing debt and extend maturities. This move aims to support future projects like the Montana Renewables MaxSAF 150 expansion, although the company still faces high debt and reliance on renewable fuel policy. The refinancing slightly eases near-term pressure but execution and cash generation are critical for the investment story.
Calumet completes $405 million senior notes offering at 9.75% By Investing.com
Calumet, Inc. (NASDAQ:CLMT) has completed a private placement of $405 million in 9.75% Senior Notes due 2031, upsized from an initial $350 million. The specialty products manufacturer, with a market cap of $1.74 billion and a significant debt load of $2.3 billion, will use the proceeds to redeem outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027. This strategic move aims to optimize the company's debt structure and eliminate near-term senior note maturities.
Calumet completes $405 million senior notes offering at 9.75% By Investing.com
Calumet, Inc. (NASDAQ:CLMT) has successfully closed a private placement of $405 million in 9.75% Senior Notes due 2031, upsized from an initial $350 million. The company plans to use the net proceeds of approximately $393 million, along with cash on hand and revolving credit, to redeem its outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027, aiming to optimize its debt structure and eliminate near-term maturities. This financial move follows strong third-quarter 2025 earnings, where EPS and revenue significantly exceeded expectations.
Calumet Specialty Products Completes Upsized Senior Notes Offering
Calumet Specialty Products' subsidiaries completed an upsized private placement of $405 million in 9.75% senior notes due 2031, with net proceeds of about $393 million. This offering, which was oversubscribed, will be used along with cash and revolver borrowings to redeem outstanding 2026 and 2027 senior notes, thereby eliminating near-term debt maturities. The move is supported by strong investor demand, recent debt reduction, and cash generation, positioning the company with a longer debt maturity runway.
Assessing Calumet’s (CLMT) Valuation After Its New Senior Unsecured Notes Offering
Calumet (CLMT) recently completed a $400.9 million senior unsecured notes offering, impacting its capital structure and future interest. Despite a forecasted 2025 net loss and a recent share price decline over the past year, the stock is considered 7.4% undervalued, trading at $19.87 against a fair value of $21.45. This valuation largely hinges on the anticipated success of its MaxSAF 150 project, expected to begin production in early 2026 and significantly boost revenues and EBITDA margins through sustainable aviation fuel production.
Calumet sees strong preliminary 2025 EBITDA, slashes debt by $220M
Calumet Specialty Products Partners anticipates strong preliminary 2025 adjusted EBITDA, projecting significant growth from 2024. The company also announced a substantial reduction in its long-term debt by $220 million, leveraging proceeds from its Montana Renewables business. These moves highlight Calumet's improved financial position and future strategic focus.
Calumet to Attend UBS Global Energy Conference and Hold Investor Meetings
Calumet, Inc. is set to attend the UBS Global Energy & Utilities Winter Conference on January 13, where it will present its market position in renewable fuels and specialty products and engage in one-on-one investor meetings to boost visibility. Analysts currently forecast an average 1-year price target of $23.67 for CLMT, with several firms maintaining "Buy" or "Hold" ratings and raising price targets based on strong business dynamics and favorable regulatory developments for renewable fuels. The company, headquartered in Indianapolis, operates extensively across North America, focusing on a diversified portfolio crucial for the energy transition.
Calumet prices $405 million in senior notes at 9.75% interest rate
Calumet, Inc. has priced a private placement of $405 million in 9.75% Senior Notes due 2031, upsized from an original $350 million. The company plans to use the proceeds, along with existing cash and revolving credit, to redeem higher-interest senior notes due in 2026 and 2027, aiming to manage its significant $2.3 billion debt. This follows recent positive Q3 2025 earnings where EPS and revenue exceeded forecasts.
Calumet prices $405 million in senior notes at 9.75% interest rate
Calumet, Inc. has announced the pricing of a private placement of $405 million in 9.75% Senior Notes due 2031, upsizing from an initial plan of $350 million. The company intends to use the proceeds, along with existing cash and credit facility borrowings, to redeem outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027 to manage its substantial debt. This follows a strong third-quarter 2025 earnings report where Calumet exceeded EPS and revenue forecasts.
Calumet (CLMT) Upsizes Note Offering to $405 Million
Calumet (CLMT) has increased its private placement of senior notes to $405 million, priced at 9.75% and maturing in 2031, reflecting strong market demand despite the company's mixed financial health. While the offering indicates confidence, financial analysis reveals concerns such as a distressed Altman Z-Score, declining gross margins, and high debt levels, suggesting caution for investors. The stock is currently trading near historical highs, with moderate buy sentiment from analysts.
Calumet Prices $405 Million Senior Notes Offering to Redeem Existing Debt
Calumet, Inc.'s subsidiaries have priced a $405 million offering of 9.75% Senior Notes, an increase from the initial $350 million, to redeem existing senior notes due in 2026 and 2027. This strategic move aims to reduce the company's interest burden and improve its financial condition. The notes will mature in 2031, reflecting strong market support and the company's intent to optimize its capital structure.
Calumet prices $405 million in senior notes at 9.75% interest rate
Calumet, Inc. has priced a private placement of $405 million in 9.75% Senior Notes due 2031, upsized from an original $350 million, to close on January 12, 2026. The company plans to use the proceeds, along with cash and revolving credit, to redeem existing higher-interest senior notes due 2026 and 2027, aiming to manage its $2.3 billion debt. This follows strong Q3 2025 earnings where EPS significantly exceeded forecasts.
Calumet Specialty Products Prices New Senior Notes Offering
Calumet Specialty Products has priced an upsized $405 million private placement of 9.75% senior notes due 2031, issued at 98.996% of par. The company plans to use the net proceeds, along with cash on hand and revolving credit facility borrowings, to redeem its outstanding 2026 and 2027 senior notes, thereby restructuring its debt maturity profile. An AI analyst has rated CLMT as "Neutral" due to weak financial health but noted a constructive earnings outlook and the refinancing plan as supportive factors.
Calumet moves to swap 11% and 8.125% debt for new 2031 notes
Calumet (NASDAQ: CLMT) announced a private placement of $350 million in senior unsecured notes due 2031. The proceeds, along with cash and revolving credit, will be used to conditionally redeem all outstanding 11.00% Senior Notes due 2026 and $275 million of the 8.125% Senior Notes due 2027. The redemptions are contingent upon the completion of an offering of at least $325 million in new senior debt securities by the applicable redemption dates in January 2026.
Calumet cuts over $220M debt as Montana Renewables secures DOE loan
Calumet (NASDAQ: CLMT) announced preliminary financial results for fiscal year 2025, anticipating a net loss between $69.0 million and $12.0 million, but with Adjusted EBITDA with Tax Attributes projected to be $285.0 million to $305.0 million. The company significantly reduced restricted debt by over $220 million, including a $110 million divestiture of Royal Purple Industrial. Additionally, its subsidiary Montana Renewables benefited from a U.S. DOE loan that eliminated approximately $80 million in annual debt service and monetized over $90 million in producer tax credits.
What Calumet (CLMT)'s 2025 Net Loss Guidance Means For Shareholders
Calumet, Inc. has issued preliminary guidance for 2025, expecting a net loss between US$69.0 million and US$12.0 million. This guidance impacts the company's investment narrative, which relies on its transition to renewables and specialty products to offset volatility and balance sheet strain. Investors will now focus on how management plans to move from these projected losses to improved margins, particularly concerning renewables and upcoming SAF capacity.
Calumet Specialty Products Announces New Senior Notes Offering
Calumet Specialty Products (CLMT) plans to offer $350 million in senior unsecured notes due 2031 to refinance existing senior debt due 2026 and 2027, thereby extending debt maturities and continuing a de-leveraging strategy. This move aligns with the company's efforts to reduce costs, enhance production in its specialty products segment, upgrade facilities, and expand its Montana Renewables operations, including the MaxSAF 150 project for sustainable aviation fuel. Despite weak financial performance and high leverage, analyst sentiment is neutral, with some optimism from cost reductions and strategic progress.
Calumet announces $350 million private placement of senior notes By Investing.com
Calumet, Inc. has announced a private placement of $350 million in senior unsecured notes due 2031 to refinance existing debt, aiming to redeem outstanding 11.00% Senior Notes due 2026 and a portion of 8.125% Senior Notes due 2027. This strategic move highlights the company's objective to manage its substantial debt position, with the redemptions contingent on the successful completion of the new debt offering. The company recently reported strong third-quarter 2025 earnings, exceeding forecasts with an EPS of $3.61 and revenue of $1.08 billion.
What Calumet (CLMT)'s 2025 Net Loss Guidance Means For Shareholders
Calumet (CLMT) has issued preliminary guidance for a 2025 net loss between US$69.0 million and US$12.0 million, tempering earlier optimism about margin expansion and renewables. This guidance places focus on execution and liquidity, with the key catalysts being progress toward margin improvement and the biggest risk remaining the company's leverage and dependence on regulatory economics. Investors will be keen to see how management frames the path from these guided losses to improved margins, particularly concerning renewables and upcoming SAF capacity.
Calumet sees FY 2025 adjusted EBITDA between $285 million and $305 million
Calumet (CLMT) projects its adjusted EBITDA for fiscal year 2025 to be between $285 million and $305 million. The company, which specializes in various oil and gas products, released this financial outlook through Reuters. This information is typically reserved for members of the platform.
With 39% stake, Calumet, Inc. (NASDAQ:CLMT) seems to have captured institutional investors' interest
Institutional investors hold a significant 39% stake in Calumet, Inc. (NASDAQ:CLMT), indicating their strong interest and potentially making the stock price sensitive to their trading actions. The top eight shareholders collectively own over 50% of the business, suggesting a balance between larger and smaller shareholder interests. Additionally, private companies hold a 17% stake, and hedge funds account for 6.6%, with insiders owning shares worth US$69 million.
